Nicotine therapeutic benefits: Difference between revisions

Line 1,070:

<br>

='''Mental Health'''=

='''Mental and Behavorial Health'''=

*See subcategories below

<br>

Line 1,103:

*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394231/pdf/nihms-950880.pdf PDF Version]

*Citation: Lewis AS, van Schalkwyk GI, Lopez MO, Volkmar FR, Picciotto MR, Sukhodolsky DG. An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder. J Autism Dev Disord. 2018 Aug;48(8):2748-2757. doi: 10.1007/s10803-018-3536-7. PMID: 29536216; PMCID: PMC6394231.

*~~Acknowledgements~~: This work was supported by Autism Speaks grant #9699 (ASL), National Institutes of Health grants R01DA14241 and R01MH077681 (MRP), R25MH071584, T32MH019961, and T32MH14276 (ASL), and the Child Study Center Associates and the AACAP Pilot Award for General Psychiatry Residents (GIvS).

*Acknowledgments: This work was supported by Autism Speaks grant #9699 (ASL), National Institutes of Health grants R01DA14241 and R01MH077681 (MRP), R25MH071584, T32MH019961, and T32MH14276 (ASL), and the Child Study Center Associates and the AACAP Pilot Award for General Psychiatry Residents (GIvS).

===2015: [https://pmc.ncbi.nlm.nih.gov/articles/PMC4486625/#S8 Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states]===

*This literature review analyzes human and animal studies exploring how nicotine and nicotinic agents may reduce aggressive behaviors and agitation in specific groups. The authors emphasize that while these findings are promising, systematic clinical trials are still in their early stages. Ultimate therapeutic success depends heavily on a person's unique psychiatric profile, underlying diagnosis, and prior smoking status.

*Citation: Picciotto MR, Lewis AS, van Schalkwyk GI, Mineur YS. Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states. Neuropharmacology. 2015 Sep;96(Pt B):235-43. doi: 10.1016/j.neuropharm.2014.12.028. Epub 2015 Jan 9. PMID: 25582289; PMCID: PMC4486625.

*Acknowledgments: This work was supported by grants MH077681, MH19961, MH014276, DA033945 and DA14241 from the National Institutes of Health.

<br>

@@ Line 1,070: / Line 1,070: @@
 <br>
-='''Mental Health'''=
+='''Mental and Behavorial Health'''=
 *See subcategories below
 <br>
@@ Line 1,103: / Line 1,103: @@
 *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394231/pdf/nihms-950880.pdf PDF Version]
 *Citation: Lewis AS, van Schalkwyk GI, Lopez MO, Volkmar FR, Picciotto MR, Sukhodolsky DG. An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder. J Autism Dev Disord. 2018 Aug;48(8):2748-2757. doi: 10.1007/s10803-018-3536-7. PMID: 29536216; PMCID: PMC6394231.
-*Acknowledgements: This work was supported by Autism Speaks grant #9699 (ASL), National Institutes of Health grants R01DA14241 and R01MH077681 (MRP), R25MH071584, T32MH019961, and T32MH14276 (ASL), and the Child Study Center Associates and the AACAP Pilot Award for General Psychiatry Residents (GIvS).
+*Acknowledgments: This work was supported by Autism Speaks grant #9699 (ASL), National Institutes of Health grants R01DA14241 and R01MH077681 (MRP), R25MH071584, T32MH019961, and T32MH14276 (ASL), and the Child Study Center Associates and the AACAP Pilot Award for General Psychiatry Residents (GIvS).
+===2015: [https://pmc.ncbi.nlm.nih.gov/articles/PMC4486625/#S8 Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states]===
+*This literature review analyzes human and animal studies exploring how nicotine and nicotinic agents may reduce aggressive behaviors and agitation in specific groups. The authors emphasize that while these findings are promising, systematic clinical trials are still in their early stages. Ultimate therapeutic success depends heavily on a person's unique psychiatric profile, underlying diagnosis, and prior smoking status.
+*Citation: Picciotto MR, Lewis AS, van Schalkwyk GI, Mineur YS. Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states. Neuropharmacology. 2015 Sep;96(Pt B):235-43. doi: 10.1016/j.neuropharm.2014.12.028. Epub 2015 Jan 9. PMID: 25582289; PMCID: PMC4486625.
+*Acknowledgments: This work was supported by grants MH077681, MH19961, MH014276, DA033945 and DA14241 from the National Institutes of Health.
 <br>